Your shopping cart is currently empty

NM-002 is a metabolite of the prodrug NM-001, characterized by its near-infrared emission properties. It is generated through the activation of NM-001 by cathepsin B (CTSB) overexpressed in tumor cells. NM-002 exhibits no toxicity to tumor cells and can escape from lysosomes to the cytoplasm. It is suitable for real-time monitoring of drug release studies.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | NM-002 is a metabolite of the prodrug NM-001, characterized by its near-infrared emission properties. It is generated through the activation of NM-001 by cathepsin B (CTSB) overexpressed in tumor cells. NM-002 exhibits no toxicity to tumor cells and can escape from lysosomes to the cytoplasm. It is suitable for real-time monitoring of drug release studies. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.